Lentigo Maligna Melanoma Therapeutic Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: L341FF84DBE2EN
Market Monitor Global

Abstracts

Lentigo maligna is a subtype of melanoma in situ that is characterized by an atypical proliferation of melanocytes within the basal epidermis; lentigo maligna that invades the dermis is termed lentigo maligna melanoma.

This report contains market size and forecasts of Lentigo Maligna Melanoma Therapeutic in Global, including the following market information:

Global Lentigo Maligna Melanoma Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lentigo Maligna Melanoma Therapeutic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lentigo Maligna Melanoma Therapeutic include Chiron Corporation, Amgen, Bristol-Myers Squibb, Merck & Co, Novartis and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lentigo Maligna Melanoma Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lentigo Maligna Melanoma Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lentigo Maligna Melanoma Therapeutic Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy

Global Lentigo Maligna Melanoma Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lentigo Maligna Melanoma Therapeutic Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Lentigo Maligna Melanoma Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lentigo Maligna Melanoma Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lentigo Maligna Melanoma Therapeutic revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lentigo Maligna Melanoma Therapeutic revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Chiron Corporation
• Amgen
• Bristol-Myers Squibb
• Merck & Co
• Novartis
• Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lentigo Maligna Melanoma Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lentigo Maligna Melanoma Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LENTIGO MALIGNA MELANOMA THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Lentigo Maligna Melanoma Therapeutic Market Size: 2021 VS 2028
2.2 Global Lentigo Maligna Melanoma Therapeutic Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lentigo Maligna Melanoma Therapeutic Players in Global Market
3.2 Top Global Lentigo Maligna Melanoma Therapeutic Companies Ranked by Revenue
3.3 Global Lentigo Maligna Melanoma Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Lentigo Maligna Melanoma Therapeutic Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lentigo Maligna Melanoma Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lentigo Maligna Melanoma Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Lentigo Maligna Melanoma Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lentigo Maligna Melanoma Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lentigo Maligna Melanoma Therapeutic Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Immunotherapy
  4.1.4 Targeted Therapy
  4.1.5 Radiation Therapy
4.2 By Type - Global Lentigo Maligna Melanoma Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2022
  4.2.2 By Type - Global Lentigo Maligna Melanoma Therapeutic Revenue, 2023-2028
  4.2.3 By Type - Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lentigo Maligna Melanoma Therapeutic Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Lentigo Maligna Melanoma Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2022
  5.2.2 By Application - Global Lentigo Maligna Melanoma Therapeutic Revenue, 2023-2028
  5.2.3 By Application - Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lentigo Maligna Melanoma Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2022
  6.2.2 By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue, 2023-2028
  6.2.3 By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2028
  6.3.2 US Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.3.3 Canada Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.3.4 Mexico Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2028
  6.4.2 Germany Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.4.3 France Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.4.4 U.K. Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.4.5 Italy Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.4.6 Russia Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.4.7 Nordic Countries Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.4.8 Benelux Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2028
  6.5.2 China Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.5.3 Japan Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.5.4 South Korea Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.5.5 Southeast Asia Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.5.6 India Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2028
  6.6.2 Brazil Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.6.3 Argentina Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2028
  6.7.2 Turkey Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.7.3 Israel Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.7.4 Saudi Arabia Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028
  6.7.5 UAE Lentigo Maligna Melanoma Therapeutic Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Chiron Corporation
  7.1.1 Chiron Corporation Corporate Summary
  7.1.2 Chiron Corporation Business Overview
  7.1.3 Chiron Corporation Lentigo Maligna Melanoma Therapeutic Major Product Offerings
  7.1.4 Chiron Corporation Lentigo Maligna Melanoma Therapeutic Revenue in Global Market (2017-2022)
  7.1.5 Chiron Corporation Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Lentigo Maligna Melanoma Therapeutic Major Product Offerings
  7.2.4 Amgen Lentigo Maligna Melanoma Therapeutic Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Major Product Offerings
  7.3.4 Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Merck & Co
  7.4.1 Merck & Co Corporate Summary
  7.4.2 Merck & Co Business Overview
  7.4.3 Merck & Co Lentigo Maligna Melanoma Therapeutic Major Product Offerings
  7.4.4 Merck & Co Lentigo Maligna Melanoma Therapeutic Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Lentigo Maligna Melanoma Therapeutic Major Product Offerings
  7.5.4 Novartis Lentigo Maligna Melanoma Therapeutic Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Lentigo Maligna Melanoma Therapeutic Major Product Offerings
  7.6.4 Roche Lentigo Maligna Melanoma Therapeutic Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lentigo Maligna Melanoma Therapeutic Market Opportunities & Trends in Global Market
Table 2. Lentigo Maligna Melanoma Therapeutic Market Drivers in Global Market
Table 3. Lentigo Maligna Melanoma Therapeutic Market Restraints in Global Market
Table 4. Key Players of Lentigo Maligna Melanoma Therapeutic in Global Market
Table 5. Top Lentigo Maligna Melanoma Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lentigo Maligna Melanoma Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lentigo Maligna Melanoma Therapeutic Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lentigo Maligna Melanoma Therapeutic Product Type
Table 9. List of Global Tier 1 Lentigo Maligna Melanoma Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lentigo Maligna Melanoma Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lentigo Maligna Melanoma Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lentigo Maligna Melanoma Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lentigo Maligna Melanoma Therapeutic Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lentigo Maligna Melanoma Therapeutic Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2023-2028
Table 30. Chiron Corporation Corporate Summary
Table 31. Chiron Corporation Lentigo Maligna Melanoma Therapeutic Product Offerings
Table 32. Chiron Corporation Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Lentigo Maligna Melanoma Therapeutic Product Offerings
Table 35. Amgen Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Product Offerings
Table 38. Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co Corporate Summary
Table 40. Merck & Co Lentigo Maligna Melanoma Therapeutic Product Offerings
Table 41. Merck & Co Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Lentigo Maligna Melanoma Therapeutic Product Offerings
Table 44. Novartis Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Lentigo Maligna Melanoma Therapeutic Product Offerings
Table 47. Roche Lentigo Maligna Melanoma Therapeutic Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lentigo Maligna Melanoma Therapeutic Segment by Type in 2021
Figure 2. Lentigo Maligna Melanoma Therapeutic Segment by Application in 2021
Figure 3. Global Lentigo Maligna Melanoma Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lentigo Maligna Melanoma Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lentigo Maligna Melanoma Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lentigo Maligna Melanoma Therapeutic Revenue in 2021
Figure 8. By Type - Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 12. US Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 16. Germany Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 17. France Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 24. China Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. India Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 30. Brazil Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lentigo Maligna Melanoma Therapeutic Revenue Market Share, 2017-2028
Figure 33. Turkey Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lentigo Maligna Melanoma Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. Chiron Corporation Lentigo Maligna Melanoma Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Lentigo Maligna Melanoma Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Lentigo Maligna Melanoma Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co Lentigo Maligna Melanoma Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Lentigo Maligna Melanoma Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Lentigo Maligna Melanoma Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)